Lorcaserin Extended-Release Tablets and Trastuzumab and Hyaluronidase
Determining the interaction of Lorcaserin Extended-Release Tablets and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Trastuzumab Injection (Intravenous)
- Lorcaserin Extended-Release Tablets-Trastuzumab Intravenous
- Lorcaserin Extended-Release Tablets-Trastuzumab-anns
- Lorcaserin Extended-Release Tablets-Trastuzumab-dkst
- Lorcaserin Extended-Release Tablets-Trastuzumab-dkst Intravenous
- Lorcaserin Extended-Release Tablets-Trasylol
- Trastuzumab and Hyaluronidase-Lorcaserin Hydrochloride
- Trastuzumab and Hyaluronidase-Lorcaserin Tablets
- Trastuzumab and Hyaluronidase-Lorcet
- Trastuzumab and Hyaluronidase-Lorcet Plus
- Trastuzumab and Hyaluronidase-Lorcet Tablets
- Trastuzumab and Hyaluronidase-Lorlatinib